|
Market Closed -
Nasdaq
16:00:00 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 7.770 USD | +1.04% |
|
-0.64% | -33.19% |
Company Valuation: CorMedix Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 173.2 | 174.1 | 206 | 491.5 | 916.3 | 599.4 | - | - |
| Change | - | 0.53% | 18.32% | 138.57% | 86.44% | -34.59% | - | - |
| Enterprise Value (EV) 1 | 107.7 | 115.3 | 130 | 439.8 | 912.4 | 490 | 452.1 | 599.4 |
| Change | - | 7.05% | 12.71% | 238.36% | 107.46% | -46.3% | -7.74% | 32.59% |
| P/E | -6.07x | -5.7x | -4.13x | -27x | 5.7x | 15.5x | 136x | 17.4x |
| PBR | 2.76x | - | 2.94x | - | 2.3x | 1.51x | 1.68x | - |
| PEG | - | 4.28x | -0.2x | 0.4x | -0x | -0.2x | -1.5x | 0x |
| Capitalization / Revenue | 907x | 2,662x | - | 11.3x | 2.94x | 1.78x | 2.07x | 1.74x |
| EV / Revenue | 564x | 1,763x | - | 10.1x | 2.93x | 1.45x | 1.56x | 1.74x |
| EV / EBITDA | - | - | - | -29.5x | 4.68x | 3.74x | 5.88x | - |
| EV / EBIT | -3.66x | -3.77x | -2.65x | -19.7x | 6.08x | 5.85x | 43.1x | 12.4x |
| EV / FCF | -4.77x | -4.69x | -3.36x | -8.67x | 5.28x | 3.62x | 6.24x | - |
| FCF Yield | -21% | -21.3% | -29.8% | -11.5% | 18.9% | 27.6% | 16% | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.75 | -0.74 | -0.91 | -0.3 | 2.04 | 0.495 | 0.0567 | 0.4425 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.1909 | 0.0654 | - | 43.47 | 311.7 | 337.1 | 289.3 | 345.3 |
| EBITDA 1 | - | - | - | -14.89 | 195.1 | 130.9 | 76.89 | - |
| EBIT 1 | -29.44 | -30.62 | -48.96 | -22.36 | 150.1 | 83.73 | 10.48 | 48.24 |
| Net income 1 | -28.21 | -29.7 | -46.34 | -17.93 | 163.1 | 45.67 | 5.329 | 42.78 |
| Net Debt 1 | -65.47 | -58.79 | -76.03 | -51.69 | -3.905 | -109.4 | -147.3 | - |
| Reference price 2 | 4.550 | 4.220 | 3.760 | 8.100 | 11.630 | 7.690 | 7.690 | 7.690 |
| Nbr of stocks (in thousands) | 38,065 | 41,260 | 54,790 | 60,677 | 78,789 | 77,944 | - | - |
| Announcement Date | 3/29/22 | 3/30/23 | 3/12/24 | 3/25/25 | 3/5/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.54x | 1.45x | 3.74x | - | 599M | |
| 107.73x | 6.01x | 25.48x | 2.3% | 365B | |
| 22.51x | 3.05x | 10.66x | 1.77% | 65.86B | |
| 15.6x | 7.61x | 11.67x | - | 12.76B | |
| 14.4x | 1.79x | 6.09x | 3.08% | 7.46B | |
| 17.92x | 5.57x | 14.88x | -.--% | 4.35B | |
| 35.53x | 2.33x | 26.43x | 0.78% | 4.05B | |
| 36.23x | 5.65x | 16.55x | - | 3.16B | |
| -216.95x | - | - | -.--% | 2.52B | |
| Average | 5.39x | 4.18x | 14.44x | 1.32% | 51.79B | |
| Weighted average by Cap. | 87.85x | 5.52x | 22.50x | 2.19% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRMD Stock
- Valuation CorMedix Inc.
Select your edition
All financial news and data tailored to specific country editions
